The Latest
-
Metcash shares: FY26 earnings highlight portfolio resilience and cost discipline
-
CSL cuts FY26 guidance, flags $5bn in impairments
-
3 ASX healthcare shares to buy while they’re on sale
-
How much could the Xero share price rise in the next year?